On Wednesday, UnitedHealth Group Inc (UNH) stock saw a modest uptick, ending the day at $596.69 which represents a slight increase of $29.66 or 5.23% from the prior close of $567.03. The stock opened ...

UnitedHealth Group (UNH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

After reaching a 52-week high heading into third-quarter earnings on October 15th, medical service plans company UnitedHealth ...

UnitedHealth Group (NYSE: UNH) is one of the most closely watched stocks on Wall Street today. As of Wednesday’s trading session, the healthcare giant is up +6.36% or $36.06, re ...

UnitedHealth Group (UNH) stock is down more than 9% in early trading Tuesday, dragging the price-weighted Dow Jones Industrial Average into the red. The selloff comes as the health insurance ...

Data by YCharts Essentially, UNH is trading at a valuation multiple that it can easily maintain based on historical trends, meaning that the stock price can increase more or less in line with EPS ...

Ascension Health, a chain of Catholic hospitals in the U.S., was the victim of a cyberattack that disrupted operations, the company said Wednesday. UnitedHealth CEO Andrew Witty testified before a ...

Wells Fargo analyst Steve Baxter maintained a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target of ...

UnitedHealth Group (UNH) has recently been on Zacks.com's list ... trends in earnings estimate revisions and short-term stock price movements. For the current quarter, UnitedHealth is expected ...

UnitedHealth Group's UNH stock price pulled back following the Q3 earnings release in what can best be described as a temper tantrum. The results weren't bad, outpacing the consensus estimates and ...

medical service plans company UnitedHealth Group (UNH) has pulled back nearly 7% in recent days. This opens the age-old question following a decline in a blue-chip stock’s share price ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...